Q: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
 The Molecule can be represented with the SMILES COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O.
Answer: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
(E)-N-[(4-hydroxy-5-methoxyphenyl)methyl]-8-methylnon-6-enamide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.